This article examines trends in biopharma post-grant patent review and projects what the future holds in store.
Scott E. Kamholz
Advertisement
Articles by Scott E. Kamholz
Advertisement
Latest Updated Articles
Are Biopharma Patents Poised on the Post-Grant Chopping Block?Published: October 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
